NCT05542485View on ClinicalTrials.gov

PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study

RecruitingOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

August 6, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

ctDNA liquid biopsy - Roche Avenio Assay

The intervention will involve plasma ctDNA testing for patients with a radiological suspicion for newly diagnosed advanced NSCLC

Trial Locations (3)

Unknown

RECRUITING

Beaumont Hospital, Dublin

RECRUITING

St. James' Hospital, Dublin

RECRUITING

University Hospital Limerick, Limerick

All Listed Sponsors
lead

Royal College of Surgeons, Ireland

OTHER

NCT05542485 - PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study | Biotech Hunter | Biotech Hunter